Literature DB >> 8915767

Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease.

S V Reddy1, F R Singer, L Mallette, G D Roodman.   

Abstract

Paget disease of bone is characterized by abnormalities in all phases of bone remodeling, but the fundamental cellular abnormality resides in the osteoclast (OCL). Osteoclasts in bone involved by Paget disease contain viral-like nuclear and cytoplasmic inclusions that react with antibodies directed against paramyxovirus nucleocapsid proteins, such as measles virus, respiratory syncytial virus, or canine distemper virus. However, the identity of the virus or the mechanisms responsible for its persistence or pathologic role in Paget disease is unclear. Furthermore, although Paget disease persists for many years, it remains a highly localized process with new lesions rarely if ever developing in previously unaffected bones. Since osteoclasts are formed by fusion of mononuclear precursors derived from colony forming unit-granulocyte macrophage (CFU-GM), the granulocyte-macrophage progenitor, we used reverse transcriptase polymerase chain reaction (RT-PCR) analysis to determine if CFU-GM, more differentiated osteoclast precursors, and peripheral blood cells derived from CFU-GM express measles virus nucleocapsid (MV-N) transcripts. We found that osteoclast precursors, as well as peripheral blood mononuclear cells, express MV transcripts in 9 of 13 patients. Sequence analysis of the PCR amplified products confirmed nucleotide identity of MV-N transcripts expressed in peripheral blood and bone marrow-derived cells from the same patient. In contrast, MV-N transcripts were not detected in OCL precursors or the peripheral blood from 10 normal subjects. In situ hybridization studies using 35S-labeled antisense riboprobes to MV-N transcripts further confirmed the expression of MV transcripts in these cells. Sequence analysis of the PCR amplified product from one of these patients also identified a novel mutation that converted lysine441 to glutamic acid441 in the MV-N transcript. These data demonstrate that OCL precursors and circulating peripheral blood cells also express MV transcripts in patients with Paget disease and suggest that the pagetic marrow microenvironment plays a critical role in maintaining the highly localized nature of the lesions in Paget disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915767     DOI: 10.1002/jbmr.5650111103

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

Review 1.  Paget's disease of bone: diagnosis and treatment update.

Authors:  M Noor; D Shoback
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

Review 2.  Paget's disease of bone: a disease of the osteoclast.

Authors:  S V Reddy; N Kurihara; C Menaa; G D Roodman
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

3.  Paget disease of bone: mapping of two loci at 5q35-qter and 5q31.

Authors:  N Laurin; J P Brown; A Lemainque; A Duchesne; D Huot; Y Lacourcière; G Drapeau; J Verreault; V Raymond; J Morissette
Journal:  Am J Hum Genet       Date:  2001-07-25       Impact factor: 11.025

Review 4.  Treatment of patients with Paget's disease of bone.

Authors:  C Roux; M Dougados
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

5.  Guidelines for diagnosis and management of Paget's disease of bone in Japan.

Authors:  Shinjiro Takata; Jun Hashimoto; Kiyoshi Nakatsuka; Noriko Yoshimura; Kousei Yoh; Ikko Ohno; Hiroo Yabe; Satoshi Abe; Masao Fukunaga; Masaki Terada; Masaaki Zamma; Stuart H Ralston; Hirotoshi Morii; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

6.  Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.

Authors:  Srinivasan Shanmugarajan; Rimon F Youssef; Parmita Pati; William L Ries; D Sudhaker Rao; Sakamuri V Reddy
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

7.  Osteoclast-derived IGF1 is required for pagetic lesion formation in vivo.

Authors:  Kazuaki Miyagawa; Yasuhisa Ohata; Jesus Delgado-Calle; Jumpei Teramachi; Hua Zhou; David D Dempster; Mark A Subler; Jolene J Windle; John M Chirgwin; G David Roodman; Noriyoshi Kurihara
Journal:  JCI Insight       Date:  2020-03-26

Review 8.  Paget's Disease of Bone.

Authors:  Luigi Gennari; Domenico Rendina; Alberto Falchetti; Daniela Merlotti
Journal:  Calcif Tissue Int       Date:  2019-01-23       Impact factor: 4.333

9.  Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

Authors:  Joseph L Shaker
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

Review 10.  Paget's disease of bone-genetic and environmental factors.

Authors:  Frederick R Singer
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.